Publication | Closed Access

Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes

Metastatic Urothelial CancerUrologyGenitourinary CancerMedicineClinical TrialsImmune Checkpoint InhibitorCancer TreatmentPhase 2OncologyRadiation OncologyHealth Sciences